Three years on: How is the industry coping with Annex 1?
The revised EU GMP Annex 1 shifts the pharmaceutical industry from fragmented compliance to a holistic, comprehensive framework. Industry expert Ian Hudson shares his insights into the deeper nuances and practical impact of these changes.
